Mechanism of Suyu tongfeng prescription in the treatment of gouty arthritis through ROS/TXNIP/NLRP3 signaling pathway

CHENG Yuan; ZHANG Li; TANG Yi; TAN Yimin; LI Juan; SONG Ying; YUAN Qianghua; TAN Xiaoyu

doi:10.6039/j.issn.1001-0408.2022.19.08

您当前的位置：

首页 >

文章列表页 >

Mechanism of Suyu tongfeng prescription in the treatment of gouty arthritis through ROS/TXNIP/NLRP3 signaling pathway

更新时间：2025-12-03

- Mechanism of Suyu tongfeng prescription in the treatment of gouty arthritis through ROS/TXNIP/NLRP3 signaling pathway
- ZHONGGUO YAOFANG Vol. 33, Issue 19, Pages: 2343-2347(2022)
- 作者机构：
  
  1.成都中医药大学附属医院药理室，成都　610072
  2.成都市新都区中医院呼吸内科，成都　610500
  3.成都中医药大学附属医院药剂科，成都　610072
  4.成都中医药大学附属医院检验科，成都　610072
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2022.19.08
  CLC： R965
- Received：25 February 2022，
  
  Revised：2022-07-22，
  
  Published：15 October 2022
- 稿件说明：
移动端阅览
程媛,张礼,唐熠等.苏萸痛风方通过ROS/TXNIP/NLRP3信号通路抗痛风性关节炎的作用机制 ^Δ[J].中国药房,2022,33(19):2343-2347.

CHENG Yuan,ZHANG Li,TANG Yi,et al.Mechanism of Suyu tongfeng prescription in the treatment of gouty arthritis through ROS/TXNIP/NLRP3 signaling pathway[J].ZHONGGUO YAOFANG,2022,33(19):2343-2347.
程媛,张礼,唐熠等.苏萸痛风方通过ROS/TXNIP/NLRP3信号通路抗痛风性关节炎的作用机制 ^Δ[J].中国药房,2022,33(19):2343-2347. DOI： 10.6039/j.issn.1001-0408.2022.19.08.

CHENG Yuan,ZHANG Li,TANG Yi,et al.Mechanism of Suyu tongfeng prescription in the treatment of gouty arthritis through ROS/TXNIP/NLRP3 signaling pathway[J].ZHONGGUO YAOFANG,2022,33(19):2343-2347. DOI： 10.6039/j.issn.1001-0408.2022.19.08.

摘要

目的

研究苏萸痛风方抗痛风性关节炎的作用机制。

方法

将雄性SD大鼠按体质量随机分为正常对照组、模型组、秋水仙碱片组（阳性对照药，0.3 mg/kg）和苏萸痛风方高、中、低剂量组（5、2.5、1.25 g/kg），每组10只。给药组大鼠每日灌胃相应药物1次（10 mL/kg），连续给药7 d。正常对照组和模型组大鼠同法灌胃等体积水。第6天给药后1 h，除正常对照组外，其余各组大鼠于关节腔注入尿酸钠复制痛风性关节炎模型。检测大鼠造模后2、6、24 h的关节肿胀度和炎症指数评分。末次给药后1 h，检测大鼠血清中氧化应激相关指标[超氧化物歧化酶（SOD）、黄嘌呤氧化酶（XOD）、丙二醛（MDA）]活性及炎症因子[白细胞介素1β（IL-1β）、IL-18、肿瘤坏死因子α（TNF-α）]水平，观察各组大鼠踝关节组织病理学变化，检测大鼠踝关节组织中硫氧还蛋白互作蛋白（TXNIP）、NOD样受体热蛋白结构域相关蛋白3（NLRP3）、凋亡相关斑点样蛋白（ASC）的表达水平。

结果

经苏萸痛风方干预后，大鼠关节肿胀度减轻、炎症指数评分降低、滑膜组织水肿改善、炎症细胞数量减少。苏萸痛风方高剂量组大鼠血清中SOD活性显著升高（

＜0.01），XOD、MDA活性以及IL-1β、IL-18、TNF-α水平均显著降低（

＜0.01），踝关节组织中ROS水平和TXNIP、NLRP3、ASC蛋白表达水平均显著降低（

＜0.05或

＜0.01）。苏萸痛风方中、低剂量组上述部分指标活性/水平也发生显著逆转（

＜0.05或

＜0.01）。

结论

苏萸痛风方可通过ROS/TXNIP/NLRP3信号通路，抑制NLRP3炎性小体激活，进而发挥抗痛风性关节炎的作用。

Abstract

OBJECTIVE

To study the mechanism of Suyu tongfeng prescription against gouty arthritis.

METHODS

Male SD rats were randomly divided into normal control group， model group， colchicine tablets group （positive control drug， 0.3 mg/kg） and high-dose， medium-dose and low-dose groups （5， 2.5， 1.25 g/kg） of Suyu tongfeng prescription according to body mass， with 10 rats in each group. The rats in the administration group were orally given the corresponding drugs once a day （10 mL/kg） for 7 consecutive days. Rats in the normal control group and model group were given equal volume of water intragastrically. On the 6th day， 1 h after administration， except for normal control group，the rats in other groups were injected with sodium urate into the joint to replicate the gouty arthritis model. The degree of joint swelling and the score of inflammatory indexes were measured at 2， 6 and 24 h after the establishment of the model. One hour after the last administration， the activity of oxidative stress related indicators [superoxide dismutase （SOD）， xanthine oxidase （XOD）， malondialdehyde （MDA）] and the levels of inflammatory factors [interleukin 1β（IL-1β）， IL-18， tumor necrosis factor α（TNF-α）] were detected in the serum. The histopathological changes of ankle joints in each group were observed； the expressions level of thioredoxin interacting protein （TXNIP）， NOD like receptor thermoprotein domain related protein 3 （NLRP3）， apoptosis related spot like protein （ASC） in the ankle joint of rats were detected.

RESULTS

After intervened with Suyu tongfeng prescription， the swelling degree of joints， the score of inflammation indexes， the edema of synovial tissue and the amount of inflammatory cells were reduced. The activity of SOD in Suyu tongfeng prescription high-dose group was increased significantly （

＜0.01）， while the activities of XOD and MDA as well as the levels of IL-1β， IL-18 and TNF-α were all decreased significantly （

＜0.01）. The level of ROS and the protein expr

essions of TXNIP， NLRP3 and ASC in ankle joint were all decreased significantly （

＜0.05 or

＜0.01）. The activities/levels of the above indexes were also significantly reversed in the middle-dose and low-dose groups of Suyu tongfeng prescription （

＜0.05 or

＜0.01）.

CONCLUSIONS

Suyu tongfeng prescription can inhibit the activation of NLRP3 inflammasome through ROS/TXNIP/NLRP3 signaling pathway， and then play the role of anti-gouty arthritis.

关键词

Keywords

references

王承德，沈丕安，胡荫奇 . 实用中医风湿病学 [M ] . 2版 . 北京：人民卫生出版社， 2009 ： 286 - 288 .

赵敏，陈婷，黄振光，等 . 1990－2019年中国痛风疾病负担研究 [J ] . 现代预防医学， 2021 ， 48 （ 21 ）： 3974 - 3978 .

高尿酸血症相关疾病诊疗多学科共识专家组 . 中国高尿酸血症相关疾病诊疗多学科专家共识 [J ] . 中华内科杂志， 2017 ， 56 （ 3 ）： 235 - 248 .

中华医学会内分泌学分会 . 中国高尿酸血症与痛风诊疗指南：2019 [J ] . 中华内分泌代谢杂志， 2020 ， 36 （ 1 ）： 1 - 13 .

张超凤，刘晓莉，李雪娟，等 . 痛风急性发作一线药物治疗方案的系统评价及药物经济学分析 [J ] . 中国新药杂志， 2021 ， 30 （ 16 ）： 1530 - 1536 .

吴芃，王亮，李海涛，等 . 高尿酸血症模型的建立及降尿酸药物的研究进展 [J ] . 中国病理生理杂志， 2021 ， 37 （ 7 ）： 1283 - 1294 .

颜家兴，王茜，朱英，等 . 中药治疗痛风的作用机制研究进展 [J ] . 中国实验方剂学杂志， 2021 ， 27 （ 12 ）： 226 - 236 .

程媛，李涓，唐熠，等 . 苏萸痛风胶囊的抗炎、镇痛及降尿酸作用实验研究 [J ] . 中药与临床， 2020 ， 11 （ 1 ）： 45 - 48，63 .

SCHRODER K ， ZHOU R B ， TSCHOPP J . The NLRP3 inflammasome：a sensor for metabolic danger? [J ] . Science ， 2010 ， 327 （ 5963 ）： 296 - 300 .

CODERRE T J ， WALL P D . Ankle joint urate arthritis in rats provides a useful tool for the evaluation of analgesic and anti-arthritic agents [J ] . Pharmacol Biochem Behav ， 1988 ， 29 （ 3 ）： 461 - 466 .

吕军，吕芳，方和金，等 . 高尿酸血症并急性痛风性关节炎大鼠模型的建立 [J ] . 中国现代医学杂志， 2013 ， 23 （ 27 ）： 11 - 16 .

刘伟伟，刘秋玉，周子正，等 . 白虎加桂枝汤对高尿酸血症并急性痛风性关节炎大鼠抗炎作用机制探究 [J ] . 中华中医药杂志， 2019 ， 34 （ 5 ）： 2254 - 2259 .

BUSSO N ， SO A . Mechanisms of inflammation in gout [J ] . Arthritis Res Ther ， 2010 ， 12 （ 2 ）： 206 .

WEN H T ， TING J P Y ， O’NEILL L A J . A role for the NLRP3 inflammasome in metabolic diseases：did Warburg miss inflammation? [J ] . Nat Immunol ， 2012 ， 13 （ 4 ）： 352 - 357 .

ROCK K L ， KATAOKA H ， LAI J J . Uric acid as a danger signal in gout and its comorbidities [J ] . Nat Rev Rheumatol ， 2013 ， 9 （ 1 ）： 13 - 23 .

CHU J ， THOMAS L M ， WATKINS S C ， et al . Cholesterol-dependent cytolysins induce rapid release of mature IL-1β from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner [J ] . J Leukoc Biol ， 2009 ， 86 （ 5 ）： 1227 - 1238 .

MUÑOZ-PLANILLO R ， KUFFA P ， MARTÍNEZ-COLÓN G ， et al . K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter [J ] . Immunity ， 2013 ， 38 （ 6 ）： 1142 - 1153 .

TSCHOPP J ， SCHRODER K . NLRP3 inflammasome activation：the convergence of multiple signalling pathways on ROS production? [J ] . Nat Rev Immunol ， 2010 ， 10 （ 3 ）： 210 - 215 .

BEGUM R ， THOTA S ， ABDULKADIR A ， et al . NADPH oxidase family proteins：signaling dynamics to disease management [J ] . Cell Mol Immunol ， 2022 ， 19 （ 6 ）： 660 - 686 .

ORHAN I E ， DENIZ F S S . Natural products and extracts as xantine oxidase inhibitors ：a hope for gout disease? [J ] . Curr Pharm Des ， 2021 ， 27 （ 2 ）： 143 - 158 .

姜楠，张晓琳，田金英，等 . 具有黄嘌呤氧化酶抑制作用的天然产物之研究进展 [J ] . 药学学报， 2021 ， 56 （ 5 ）： 1229 - 1237 .

袁牧，王昌留，王一斐，等 . 超氧化物歧化酶的研究进展 [J ] . 中国组织化学与细胞化学杂志， 2016 ， 25 （ 6 ）： 550 - 558 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on metabolites derived from Zhideke granules in rats in vivo

Effects of Yiru tiaojing granules on the pharmacokinetics of olanzapine in rats

Improvement effects of Shangke xiaoyan hydrogel plaster on osteoarthritis model rats

Study on protective effects of twin drugs of tetramethylpyrazine-scutellarein on cerebral ischemia-reperfusion injury model rats and its mechanism

Intervention effect and mechanism of Zhongfeng yure decoction on ischemic stroke model rats

Related Author

ZHENG Piaoxue

CHEN Huihua

HUANG Chunyan

LIANG Yanli

LU Chunlian

XIE Jingjing

MA Yuming

PENG Jiawen

Related Institution

Dept. of Pharmacy， Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine

Qinzhou Inspection and Testing Center

Guangxi Zhuang Yao Medicine Engineering Technology Research Center

National Engineering Research Center South China Branch of TCM Solid Preparation Manufacturing Technology

Guangxi Universities Laboratory of TCM Extraction， Purification and Quality Analysis

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰